Katja Thomas

938 total citations
20 papers, 689 citations indexed

About

Katja Thomas is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Katja Thomas has authored 20 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Katja Thomas's work include Multiple Sclerosis Research Studies (13 papers), Immunotherapy and Immune Responses (6 papers) and Polyomavirus and related diseases (5 papers). Katja Thomas is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Immunotherapy and Immune Responses (6 papers) and Polyomavirus and related diseases (5 papers). Katja Thomas collaborates with scholars based in Germany, Switzerland and Israel. Katja Thomas's co-authors include Tjalf Ziemssen, Undine Proschmann, Raimar Kern, Rocco Haase, Thorsten Schultheiß, Sandra Thiel, Kerstin Hellwig, Simone Kern, Heinz Reichmann and Andrew Chan and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Medical Internet Research.

In The Last Decade

Katja Thomas

20 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Thomas Germany 16 465 192 139 120 103 20 689
Mark Rametta United States 10 530 1.1× 168 0.9× 128 0.9× 76 0.6× 127 1.2× 19 700
T. Moreau France 10 398 0.9× 251 1.3× 130 0.9× 126 1.1× 132 1.3× 23 884
Rachel Farrell United Kingdom 14 359 0.8× 160 0.8× 164 1.2× 131 1.1× 136 1.3× 44 755
Pål Berg‐Hansen Norway 16 475 1.0× 118 0.6× 70 0.5× 127 1.1× 148 1.4× 40 699
Maria Lopez-Bresnahan United States 13 418 0.9× 110 0.6× 121 0.9× 56 0.5× 214 2.1× 15 692
Brandon Beaber United States 8 458 1.0× 141 0.7× 57 0.4× 59 0.5× 115 1.1× 12 640
Jihad Inshasi United Arab Emirates 15 483 1.0× 79 0.4× 135 1.0× 69 0.6× 179 1.7× 68 715
José Manuel García‐Domínguez Spain 14 346 0.7× 79 0.4× 102 0.7× 74 0.6× 132 1.3× 52 609
Sibyl Wray United States 14 442 1.0× 219 1.1× 157 1.1× 59 0.5× 175 1.7× 58 628
Sonu M. Brara United States 8 436 0.9× 117 0.6× 53 0.4× 61 0.5× 152 1.5× 11 667

Countries citing papers authored by Katja Thomas

Since Specialization
Citations

This map shows the geographic impact of Katja Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Thomas more than expected).

Fields of papers citing papers by Katja Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Thomas. The network helps show where Katja Thomas may publish in the future.

Co-authorship network of co-authors of Katja Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Thomas. A scholar is included among the top collaborators of Katja Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Thomas. Katja Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ziemssen, Tjalf, Hayrettin Tumani, Katja Thomas, et al.. (2017). Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS. Journal of Neuroinflammation. 14(1). 172–172. 15 indexed citations
2.
Thomas, Katja, et al.. (2017). Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation. Journal of Neuroinflammation. 14(1). 41–41. 51 indexed citations
3.
Haase, Rocco, Katja Thomas, Undine Proschmann, et al.. (2017). Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?. Multiple Sclerosis Journal. 24(10). 1337–1346. 19 indexed citations
4.
Proschmann, Undine, Katja Thomas, Sandra Thiel, Kerstin Hellwig, & Tjalf Ziemssen. (2017). Natalizumab during pregnancy and lactation. Multiple Sclerosis Journal. 24(12). 1627–1634. 42 indexed citations
5.
Ziemssen, Tjalf & Katja Thomas. (2017). Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world. Therapeutic Advances in Neurological Disorders. 10(10). 343–359. 80 indexed citations
6.
Thomas, Katja, Undine Proschmann, & Tjalf Ziemssen. (2017). Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis. Expert Opinion on Pharmacotherapy. 18(15). 1649–1660. 37 indexed citations
7.
Kern, Raimar, et al.. (2016). Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System. Interactive Journal of Medical Research. 5(1). e2–e2. 38 indexed citations
8.
9.
10.
Thomas, Katja, et al.. (2016). Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS. Neurology Neuroimmunology & Neuroinflammation. 3(3). e228–e228. 65 indexed citations
11.
Ziemssen, Tjalf, Raimar Kern, & Katja Thomas. (2016). Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach. BMC Neurology. 16(1). 124–124. 68 indexed citations
12.
Thomas, Katja, et al.. (2016). Laquinimod in the treatment of relapsing remitting multiple sclerosis. Expert Opinion on Drug Metabolism & Toxicology. 12(6). 701–709. 5 indexed citations
13.
Thomas, Katja, et al.. (2016). Hands on Alemtuzumab-experience from clinical practice: whom and how to treat. 1(1). 28 indexed citations
14.
Thomas, Katja, et al.. (2014). Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease. BMC Neurology. 14(1). 126–126. 5 indexed citations
15.
Thomas, Katja, Rebekka Wehner, Imke Metz, et al.. (2014). Accumulation and therapeutic modulation of 6-sulfo LacNAc + dendritic cells in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 1(3). e33–e33. 24 indexed citations
16.
Kern, Simone, et al.. (2013). Cortisol Awakening Response Is Linked to Disease Course and Progression in Multiple Sclerosis. PLoS ONE. 8(4). e60647–e60647. 41 indexed citations
17.
Ziemssen, Tjalf, et al.. (2013). Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients. Journal of Neural Transmission. 120(S1). 61–66. 38 indexed citations
18.
Thomas, Katja & Tjalf Ziemssen. (2013). Management of fingolimod in clinical practice. Clinical Neurology and Neurosurgery. 115. S60–S64. 17 indexed citations
19.
Thomas, Katja, Thorsten Schultheiß, & Tjalf Ziemssen. (2013). Neuroborreliosis during natalizumab treatment in multiple sclerosis. Neurology. 81(11). 1012–1014. 1 indexed citations
20.
Haase, Rocco, et al.. (2012). Use and Acceptance of Electronic Communication by Patients With Multiple Sclerosis: A Multicenter Questionnaire Study. Journal of Medical Internet Research. 14(5). e135–e135. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Rametta Breakdown of academic impact, for papers by T. Moreau Breakdown of academic impact, for papers by Rachel Farrell Breakdown of academic impact, for papers by Pål Berg‐Hansen Breakdown of academic impact, for papers by Maria Lopez-Bresnahan Breakdown of academic impact, for papers by Brandon Beaber Breakdown of academic impact, for papers by Jihad Inshasi Breakdown of academic impact, for papers by José Manuel García‐Domínguez Breakdown of academic impact, for papers by Sibyl Wray Breakdown of academic impact, for papers by Sonu M. Brara
Rankless by CCL
2026